StockWatch
Ā·
SMC GLOBAL SECURITIES LTD Ā· QQ1 FY-2027 Ā· THE CALL

Diversified growth masks NBFC stumble

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q1 FY27 resultsSMCGLOBALSMC Global Securities Ltd02 Aug 2026 Ā· 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade B

Hit consolidated revenue target (₹515.1 Cr vs actual); missed NBFC AUM guidance (8.3% decline vs 15–20% expected); beat insurance guidance (44% vs 15% expected).

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Broking and insurance revenue momentum is real (21.2% and 44.4% YoY), but the group is burning shareholder value in transition: NBFC AUM fell 8.3% QoQ despite 15–20% prior guidance, and insurance EBIT margin collapsed to 1% as the business scales. Management's 20% CAGR aspiration hangs on a) insurance sustaining that 44% growth (structural, plausible) and b) NBFC stabilizing (delayed by product repositioning, needs 1–2 years per CFO). Near-term risk is uneven: broking solid, insurance revenue surges but profits lag, NBFC needs a rebound. Credibility is mixed; missed NBFC but hit overall revenue. Neutral stance reflects guidance miss on the NBFC anchor, offset by insurance upside.

₹515.1 Cr

Revenue Ā· +21.2% YoY

₹36.7 Cr

Reported PAT Ā· +22.7% YoY

Flat

Margins Ā· vs guidance: Mixed

Did the claims hold up?

Management's claims vs. the numbers

NBFC AUM recovery on track for FY27

MISS

NBFC AUM declined 8.3% QoQ to ₹1,025 Cr from ₹1,118 Cr; guidance was 15–20% growth annually

Insurance segment momentum strong, 15% growth expected

OVERSTATED

Insurance revenue grew 44.4% YoY to ₹167.3 Cr; vastly exceeded prior guidance

Broking revenue steady despite derivatives headwind

MET

Broking revenue +15.1% YoY to ₹316.3 Cr; cash market brokerage rose to 55% from 45%

Insurance EBIT compression temporary due to distribution investment

MET

Insurance EBIT only ₹1.6 Cr despite ₹167.3 Cr revenue; margin ~1%, vs prior quarter likely higher

Overall PAT growth 22% reflects consistent execution

MET

PAT grew 22.7% YoY, aligned with revenue growth 21.2%; NBFC drag offset by broking/insurance scale

Earnings quality

What changed since the last call

Deltas vs. the prior call

NBFC guidance downgrade (product repositioning)

Downgrade

Prior: 15–20% AUM growth annually. Actual Q1: -8.3% QoQ. Closed LAP (₹50 Cr decline) & unsecured (₹40 Cr decline) to shift to secured retail. FY27 closing target ₹1,250–1,300 Cr (7–27% recovery over 3Q, lower than prior multi-year target).

Insurance growth inflection (outpacing guidance)

Upgrade

Prior: 15% growth expected. Actual Q1: +44.4% YoY. Driven by non-life surge (90% of premium). But EBIT compressed due to distribution & tech capex for reinsurance opportunity; margin recovery timing now key.

Broking derivatives to cash market mix shift (structural)

Neutral

Regulatory headwind on derivatives (prior year measure impact), management notes market participants shifting to delivery-based trading. Broking MTF/T+5 book rose ₹140 Cr (₹760 to ₹900 Cr); cash brokerage % up 45 to 55%.

The Q&A

Q&A was direct and low-pressure. Analysts probed NBFC miss, insurance EBIT, and 5-year strategy. Management acknowledged AUM decline, explained product mix rationale (shift to secured, higher yields), and stood by 20% CAGR aspiration with 1–2 year caveat on NBFC. Tone: not defensive, but cautious.

The exchanges that mattered

NBFC AUM guidance miss — Manish Bhandari, Quantum Shares

Answered

AUM ₹1,025 Cr (Q1) vs ₹1,118 Cr (Q4), slight decline. Focused on secured retail (Micro LAP, Gold Loan). Discontinued LAP (-₹50 Cr) and tightened unsecured business loans (-₹40 Cr) as precaution. FY27 closing target ₹1,250–1,300 Cr. Q1 slow; focus products picking up. 5-year CAGR aim 20–25%, but expect 1–2 year ramp before that materialization.

Insurance EBIT compression vs revenue growth — Aditya Dhar, GAAB Investments

Answered

Primarily investing in manpower; corporate & life insurance headcount costs rising. Expect operating leverage in future quarters as results flow. Also investing in distribution & tech infrastructure for reinsurance license opportunity.

Broking revenue drivers Q1 amid derivatives slowdown — Aditya Dhar, GAAB Investments

Answered

Nifty/Sensex +6–7%; DII inflows >₹2 lakh Cr (FPI outflow ~₹1.5 lakh Cr). Geopolitical crisis settling (crude down). Cash market business increased, MTF/T+5 up ₹140 Cr, cash brokerage % up 45–55%. Shift from derivatives to cash; bullish on Indian economy.

5-year company strategy & revenue targets — Yash Choudhury, Investor

Partial

India GDP 7% CAGR. Capital markets beneficiary. SMC leading player, 4,000+ employees, 400+ city presence, 200 branches, all stock exchange memberships. SMC CAGR 20% YoY, will grow faster. FY27 revenue ~₹2,000 Cr; if 20% CAGR, ₹6,000–8,000 Cr in 5 years. Current PAT ₹103 Cr (FY26); expecting ₹170 Cr.

NBFC NIM outlook & interest rate sensitivity — Aditya Dhar, Cabin Investments

Answered

Q1: reduced weighted cost of funds by ~25 bps. Annual reset on existing borrowings at lower rates; new borrowings also lower. Cost reduction 25 bps. NIM focus: increasing blended yield of AUM via high-yielding retail products. Expect NIM to grow gradually over coming years.

Stoxkart platform performance & scaling — Aditya Dhar, Cabin Investments

Answered

Last 5Q strong. Quadrupled revenue YoY: Q1 2025 base vs Q1 2026 = ₹20 Cr (reported as Q1 2026 contributed ₹20 Cr). Opened ~26,000 subscription clients (Smart Trader Plan: upfront subscription for software + trading). Model new to industry, mimics SaaS. Very hopeful sizable business going forward, major contribution to SMC revenues.

AI & digital roadmap — Manish Bhandari, Quantum Shares

Answered

Built AI enablement base past 6 months. Launched AI Chatbot (proprietary low-language model, own AI agent, cost-efficient). Launched AI Algo platform (aggressive). Integrating AI in mobile app: AI-generated insights via proprietary research, script analysis, trend analysis. Testing; launch very soon.

Guidance

Forward guidance and management's confidence

Consolidated FY27 revenue on track; no specific FY27 target disclosed

Medium

Chairman expects ₹2,000 Cr+ FY27 base (implies low incremental from Q1 run rate ₹2.06 Cr annualized); 20% CAGR over 5 years would reach ₹6,000–8,000 Cr by FY32

Insurance revenue: prior 15% growth; Q1 achieved 44.4%

High

Structural tailwind (insurance penetration, regulatory tailwind, distribution network expansion). Reinsurance license deployment expected H2 FY27+

NBFC AUM closing FY27: ₹1,250–1,300 Cr

Medium

Implies 7–27% recovery from Q1 ₹1,025 Cr over 3 quarters. Prior guidance was 15–20% annualized growth; now throttled due to product repositioning

Insurance margin recovery deferred; expect operating leverage future quarters

Medium

Q1 EBIT ₹1.6 Cr (1% margin) vs prior likely 5–8%. Investments in distribution/tech for reinsurance opportunity; timing of inflection undefined

NBFC NIM expected to grow gradually over coming years via secured product mix shift

High

Cost of funds -25 bps Q1. Blended yield increasing as book shifts to high-yielding retail (Micro LAP, Gold Loan). Secured products have higher spreads

Broking EBIT margin stable; EBIT growth tracking revenue on cost discipline

High

Q1 EBIT ₹74.3 Cr on ₹316.3 Cr revenue = 23.5% margin; +17.6% YoY growth shows operating leverage from fixed-cost absorption

Risks the call surfaced

Ranked by how much they should concern a holder

NBFC AUM decline & recovery risk

High

NBFC AUM ₹1,025 Cr (Q1) vs ₹1,118 Cr (Q4 FY26) = -8.3% QoQ. Prior guidance 15–20% annual growth. Discontinued LAP (-₹50 Cr) & unsecured loans (-₹40 Cr) explain ~₹90 Cr, leaving unexplained softness. If FY27 closing target (₹1,250–1,300 Cr) misses, signals demand weakness beyond product mix shift.

Insurance EBIT margin compression

Medium

Insurance segment revenue ₹167.3 Cr (+44.4% YoY) but EBIT only ₹1.6 Cr (~1% margin). Prior quarter likely 5–8% EBIT margin. Management attributes to distribution headcount & tech capex for reinsurance license opportunity. Risk: if margin recovery delayed or insufficient, insurance business becomes a growth-without-profit drag despite strong premium growth.

Derivatives regulation headwind & market volatility

Medium

Broking revenue +15.1% YoY driven by cash market shift (45→55% brokerage %, MTF book +₹140 Cr). But derivatives segment under regulatory pressure (regulatory measures over past year cited by management). Risk: if derivatives revenue continues to erode faster than cash market compensates, broking growth could decelerate.

Execution risk on tech/AI roadmap

Low

Management committed to AI chatbot, AI Algo platform, mobile app AI insights (script analysis, trend analysis). All flagged as 'testing' or 'launching very soon.' Risk: if rollout delayed or features underperform vs. peer offerings, competitive differentiation and cost efficiency claims may not materialize.

Management

Score 7/10. Direct & candid on misses (NBFC AUM decline acknowledged, explained by product repositioning). Insurance EBIT compression contextualized as temporary investment phase. No deflection or jargon; specific numbers on AUM, revenue, EBIT. Transparency moderate: withheld some specifics on AI rollout timeline, reinsurance license deployment. Mixed track record. Hit consolidated revenue (₹515.1 Cr). Missed NBFC guidance (8.3% AUM decline vs 15–20% prior). Beat insurance (44.4% vs 15%). Broking on track. Stoxkart 4x YoY revenue growth is tangible execution win. NBFC repositioning under way but timing of CAGR recovery uncertain.

What to watch next
  • 1 Ā· Q2 FY27 (Sept 2026)

    Broking revenue trajectory & derivative vs cash mix normalization post-geopolitical calm

  • 2 Ā· FY27 full year

    NBFC AUM recovery to ₹1,250–1,300 Cr target; insurance margin inflection post-investments

  • 3 Ā· H2 FY27

    Insurance reinsurance license monetization & composite broker license deployment

Neutral stance reflects guidance miss on the NBFC anchor, offset by insurance upside.

Informational and educational content only. Not investment advice.